Dr. John Francis Ling III, MD

Dr. Ling practices at SoCal Eye Surgery Center in Long Beach, California.

Dr. Ling's NPI, 1023436391, was assigned on April 2, 2014. Dr. Ling graduated from Indiana University School Of Medicine in 2014. Dr. Ling holds California license A155679.

Dr. Ling's primary practice is SoCal Eye Surgery Center, at 3300 East South St, Long Beach, CA 90805. The practice phone is (562) 531-2020.

Dr. Ling's primary practice is SoCal Eye Surgery Center in Long Beach, California. Dmand AI also links Dr. Ling to 3 medical groups, each named with a free account. Dr. Ling's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ling practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ling's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ling is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Ling is licensed in California.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Ling treats.

CMS data shows 1,522 Medicare services from Dr. Ling across 16 procedure codes in 2024, for 494 Medicare patients. Medicare paid $110,540 for them.

CMS counts 494 Medicare patients who saw Dr. Ling in 2024. The largest group is 65 to 74, with 233 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ling's median patient age at 73, with 57% women.

In 2024, Dr. Ling wrote 4,899 Medicare Part D claims for 932 patients. 63% of them were for generic drugs. CMS names the drug for 4,835 of them, across 32 drugs with 11 or more claims each, at $530,992 in total drug cost. In 2023, CMS named 4,494 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ling for performance year 2024, reported as part of a group. Dr. Ling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 75 procedures of cataract surgery by Dr. Ling, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Ling, published from 2017 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Healthy Volunteers, Area Under Curve and Drug Interactions. Dr. Ling has published most often in Clin Pharmacokinet. Dr. Ling's most frequent co-authors are Martin S. Rhee, MD, Rebecca Anne Evans Begley, MD and Diana Marina Brainard, MD.

CMS Open Payments shows 126 general payments to Dr. Ling from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Aerie Pharmaceuticals, Inc. paid the most, $8,180.

Dr. Ling graduated from Indiana University School Of Medicine in 2014.

Dr. Ling is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.